Cost Effectiveness of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in China
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2294
https://www.valueinhealthjournal.com/article/S1098-3015(14)04224-7/fulltext
Title :
Cost Effectiveness of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04224-7&doi=10.1016/j.jval.2014.08.2294
First page :
A638
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1752